RANI 50MG /2ML 5 AMP

EACH 2 ML CONTAINS : Ranitidine ( as hydrochloride ) 50 mg .

13.50 EGP

Out of stock

RANI 50MG /2ML 5 AMP; ranitidine, gastrointestinal agents .

ACTIVE-INGREDIENT OF RANI 50MG /2ML 5 AMP

EACH 2 ML CONTAINS : Ranitidine ( as hydrochloride ) 50 mg .

INDICATION OF RANI 50MG /2ML 5 AMP

rani injection is indicated for the treatment of doudonal ulcer , benign gastric ulcer , post-operative ulcer , reflux oesophagitis , zollonger-Ellison syndrome , and the following conditions where reduction of gastric secretion and acid output is desirable : the prophylaxis of gastro-intestinal hemorrhage from stress ulceration in seriously ill patients , the prophylaxis of recurrent hemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (mendelson’s syndrome ) , particularly obstetric during labour .

DOSAGE OF RANI 50MG /2ML 5 AMP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

rani injection may be given either as slow (over a period of at least 2 minutes ) intravenous injection of 50 mg , after dilution to a volume of 20 ml per 50 mg dose , which may be repeated every 6 to 8 hours ; or as an intermittent intravenous infusion at a rate of 25 mg per hours for 2 hours , the infusion may be repeated at 6 to 8 hour intervals or as an intramuscular injection to 50 mg (2 ml ) every six to eight hours . in the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration , parenteral administration may be continued until oral feeding commences . in the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriousely ill patients a priming dose of 50 mg as a slow intravenous injection followed by a continuous intravenous infusion of 0.125 -0.25 mg/kg/hr may be preferred . in patients considered to be risk of developing acid aspiration syndrome . rani injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before reduction of general anaesthesia . children : the use of rani injection in children has not been evaluated . rani injection has been shown to be compatible with the following intravenous infusion fluids : 0.9 % sodium chloride BP . 5 % dextrose BP . 0.18 % SODIUM CHLORIDE AND 4 % dextrose BP . 4.2 SODIUM Bicarbonate . hartmann’s solution . all unused admixtures of rani injection with infusion fluids should be discarded 24 hours after preparation .

OVER-DOSAGE OF RANI 50MG /2ML 5 AMP

CONTRA-INDICATION OF RANI 50MG /2ML 5 AMP

ranitidine is contraindicated for patients known to have hypersensitivity to the drug .

STORAGE OF RANI 50MG /2ML 5 AMP

keep at temperature (15-30 c ) , away from light . Keep out of the reach of children .
PACK OF RANI 50MG /2ML 5 AMP
a box containing 5 ampoules
RANI 50MG /2ML 5 AMP MANUFACTURED BY
PHARCO B INTERNATIONAL FOR PHARCO PHARMACEUTICALS

https://www.fda.gov/news-events/press-announcements/fda-requests-removal-all-ranitidine-products-zantac-market

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Be the first to review “RANI 50MG /2ML 5 AMP”

Your email address will not be published.

Shopping Cart
Don`t copy text!
Scroll to Top